Compounds > gsk573719

gsk573719 and apremilast

gsk573719 has been researched along with apremilast* in 2 studies

Other Studies

2 other study(ies) available for gsk573719 and apremilast

ArticleYear
New drugs 2015, part 1.
    Nursing, 2015, Volume: 45, Issue:4

    Topics: Benzhydryl Compounds; Benzyl Alcohols; Chlorobenzenes; Dibenzazepines; Drug Approval; Estrogens, Conjugated (USP); Glucosides; Humans; Indoles; Nitriles; Pyridones; Pyrimidines; Quinuclidines; Thalidomide; United States; United States Food and Drug Administration

2015
Drug updates and approvals: 2014 in review.
    The Nurse practitioner, 2014, Dec-13, Volume: 39, Issue:12

    This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.

    Topics: Allergens; Benzhydryl Compounds; Benzyl Alcohols; Chlorobenzenes; Drug Approval; Dry Powder Inhalers; Glucagon-Like Peptide 1; Glucosides; Humans; Insulin; Lactones; Nurse Practitioners; Phleum; Plant Extracts; Pollen; Pyrazoles; Pyridines; Pyrimidines; Quinuclidines; Thalidomide; United States; United States Food and Drug Administration

2014